NVIDIA
NVDA
Tesla
TSLA
Broadcom
AVGO
4
Palantir
PLTR
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
ICUI ICU Medical
- 141.970
- -0.250-0.18%
Close Mar 7 16:00 ET
- 141.970
- 0.0000.00%
Post 20:01 ET
3.48BMarket Cap-29.39P/E (TTM)
145.260High139.375Low245.07KVolume141.760Open142.220Pre Close34.90MTurnover1.09%Turnover RatioLossP/E (Static)24.52MShares196.26152wk High1.77P/B3.21BFloat Cap93.35552wk Low--Dividend TTM22.59MShs Float321.700Historical High--Div YieldTTM4.14%Amplitude4.833Historical Low142.416Avg Price1Lot Size
ICU Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.44%2.38B | 7.14%629.81M | 6.47%589.13M | 8.58%596.46M | -0.35%566.66M | -0.92%2.26B | 1.70%587.86M | -7.45%553.31M | -2.08%549.31M | 4.70%568.65M |
| Operating revenue | 5.44%2.38B | 7.14%629.81M | 6.47%589.13M | 8.58%596.46M | -0.35%566.66M | -0.92%2.26B | 1.70%587.86M | -7.45%553.31M | -2.08%549.31M | 4.70%568.65M |
| Cost of revenue | 2.50%1.56B | -3.30%402.55M | 4.03%384.28M | 8.98%389.03M | 1.28%381.41M | -3.98%1.52B | 3.28%416.27M | -10.22%369.39M | -9.26%356.98M | 0.62%376.61M |
| Gross profit | 11.48%824.78M | 32.45%227.26M | 11.38%204.85M | 7.85%207.43M | -3.54%185.24M | 6.04%739.87M | -1.92%171.59M | -1.33%183.92M | 14.76%192.33M | 13.75%192.04M |
| Operating expense | 5.11%727.38M | 2.36%181.2M | 8.41%183.74M | 5.62%182.94M | 4.16%179.5M | -1.32%692.04M | 6.40%177.03M | -4.01%169.48M | -4.47%173.2M | -2.68%172.33M |
| Selling and administrative expenses | 5.29%638.76M | 2.74%158.85M | 9.49%162.71M | 5.74%159.55M | 3.33%157.66M | -0.27%606.69M | 8.17%154.62M | -3.16%148.61M | -4.95%150.9M | -0.42%152.57M |
| Research and development costs | 3.83%88.62M | -0.25%22.36M | 0.76%21.03M | 4.88%23.39M | 10.53%21.84M | -8.22%85.34M | -4.41%22.41M | -9.67%20.87M | -1.15%22.3M | -17.22%19.76M |
| Operating profit | 103.62%97.41M | 946.11%46.05M | 46.23%21.12M | 28.01%24.49M | -70.85%5.75M | 1,440.70%47.84M | -163.54%-5.44M | 46.77%14.44M | 239.46%19.13M | 338.71%19.71M |
| Net non-operating interest income expense | -0.56%-95.75M | 3.90%-23.46M | -2.10%-24.68M | 1.16%-23.84M | -5.58%-23.77M | -43.46%-95.22M | -21.60%-24.41M | -35.75%-24.18M | -56.22%-24.12M | -72.46%-22.52M |
| Non-operating interest income | 43.69%10.79M | 18.84%2.73M | 49.14%2.6M | 63.96%2.81M | 51.06%2.65M | 69.48%7.51M | 785.97%2.3M | -47.77%1.75M | 105.52%1.71M | 197.28%1.75M |
| Non-operating interest expense | 3.71%106.54M | -1.94%26.19M | 5.27%27.29M | 3.15%26.65M | 8.86%26.42M | 45.08%102.73M | 35.31%26.71M | 22.55%25.92M | 58.75%25.83M | 77.85%24.27M |
| Other net income (expense) | -118.86%-67.66M | -110.54%-14.38M | -428.80%-14.36M | -12.92%-20.18M | -77.10%-18.74M | 30.47%-30.92M | 31.29%-6.83M | 132.75%4.37M | -245.27%-17.87M | 68.40%-10.58M |
| Gain on sale of security | -65.46%-9.79M | -78.67%-4.59M | 64.82%-1.06M | -382.83%-2.42M | -1,164.20%-1.72M | -2.39%-5.92M | -115.34%-2.57M | -45.27%-3.01M | 81.71%-501K | -27.35%162K |
| Special income (charges) | -122.73%-56.05M | -68.04%-9.95M | -262.96%-12.98M | -1.12%-16.79M | -53.96%-16.34M | 39.92%-25.16M | 34.38%-5.92M | 168.25%7.97M | -227.43%-16.6M | 68.99%-10.61M |
| -Less：Restructuring and merger&acquisition | 117.67%54.44M | 24.08%8.36M | 253.13%12.88M | 2.61%16.8M | 59.02%16.4M | -36.41%25.01M | -23.30%6.74M | -181.62%-8.41M | 219.76%16.37M | -69.58%10.31M |
| -Gain on sale of property,plant,equipment | -950.98%-1.61M | -293.29%-1.59M | 77.58%-100K | 105.24%12K | 121.89%65K | 94.01%-153K | 451.93%820K | 67.35%-446K | 64.39%-229K | 4.81%-297K |
| Other non- operating income (expenses) | -1,198.19%-1.82M | -90.48%158K | 45.24%-322K | -26.55%-977K | -408.96%-682K | -94.81%166K | 507.69%1.66M | -244.83%-588K | -138.29%-772K | -126.59%-134K |
| Income before tax | 15.69%-66.01M | 122.40%8.22M | -234.10%-17.93M | 14.57%-19.53M | -174.61%-36.77M | 31.56%-78.3M | -71.03%-36.68M | 74.82%-5.37M | -35.65%-22.86M | 75.57%-13.39M |
| Income tax | 206.23%51.68M | 264.05%32.05M | 219.45%15.06M | 114.49%1.87M | 175.57%2.7M | -21.24%-48.64M | -230.47%-19.53M | -55.62%-12.6M | -37.84%-12.93M | 78.62%-3.58M |
| Net income | -296.86%-117.69M | -38.96%-23.83M | -555.69%-32.98M | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M |
| Net income continuous Operations | -296.86%-117.69M | -38.96%-23.83M | -555.69%-32.98M | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -296.86%-117.69M | -38.96%-23.83M | -555.69%-32.98M | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -296.86%-117.69M | -38.96%-23.83M | -555.69%-32.98M | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M |
| Basic earnings per share | -292.68%-4.83 | -36.62%-0.97 | -550.00%-1.35 | -114.63%-0.88 | -297.56%-1.63 | 60.45%-1.23 | -9.23%-0.71 | 154.55%0.3 | -32.26%-0.41 | 74.53%-0.41 |
| Diluted earnings per share | -292.68%-4.83 | -36.62%-0.97 | -550.00%-1.35 | -114.63%-0.88 | -297.56%-1.63 | 60.45%-1.23 | -9.23%-0.71 | 154.55%0.3 | -32.26%-0.41 | 74.53%-0.41 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |